Login
|
Register
News
Media
Insights
Peer Exchange
OncNurse TV
Webinars
Podcasts
Resources
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancers
Supportive Care
Blood Cancers
Prevention
Genetics
Nurse Navigation
Immuno-Oncology
Drug Safety
Skin Cancer/Melanoma
Brain Cancer
Childhood/AYA Cancer
Head and Neck Cancers
Adverse Event Management
Contributors
Conferences
Partners
Advocacy
Associations
Schools of Nursing
Publications
CE
Register now to learn about a new option for relapsed or refractory follicular lymphoma
Head and Neck Cancers
Pembrolizumab Shows OS Benefit in PD-L1+ Esophageal Cancer
BY GINA COLUMBUS
Nivolumab Extends Survival in Advanced or Recurrent Esophageal Cancer
BY GINA COLUMBUS
BLU-667 Shows Clinical Benefit in Advanced, RET-Altered Solid Tumors
BY KRISTIE L. KAHL
Improved Quality of Life for Head and Neck Cancer Patients with Nivolumab
BY JASON HARRIS
Cancer Prevention Foundation: Why boys need the HPV vaccine, too
BY PREVENT CANCER FOUNDATION
Oncology Found Her: Going the Extra Mile for Patients With Head and Neck Cancer
BY KATHY LATOUR
HPV on the Rise
BY LISA SCHULMEISTER, RN, MN, APRN-BC, FAAN
A Four-Step Approach to Psychosocial Care in Head and Neck Cancer
BY LAUREN M. GREEN
NFL Star Jim Kelly Discusses Your Cancer Game Plan
BY ALLIE CASEY
Treatment Informed by PET Imaging Linked to Better Response Rates in Esophageal Cancer
BY JASON M. BRODERICK
<< Prev Page
Next Page >>
External Resources
MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources
Newsroom
Continuing Education
Discussions
Web Exclusives
About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747
Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.